Drilling into the Technicals & Valuation For BioMarin Pharmaceutical Inc. (NasdaqGS:BMRN), W.W. Grainger, Inc. (NYSE:GWW)

Stock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The Volatility 12m of BioMarin Pharmaceutical Inc. (NasdaqGS:BMRN) is 31.847800.  This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.  The lower the number, a company is thought to have low volatility.  The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months.  The Volatility 3m of BioMarin Pharmaceutical Inc. (NasdaqGS:BMRN) is 35.281500.  The Volatility 6m is the same, except measured over the course of six months.  The Volatility 6m is 35.221400.

Investors who are able to wipe the slate clean and take a fresh look at a certain stock may be able to make more informed decisions that will hopefully lead to increased profits in the long-term. Figuring out when to sell an underperforming stock may end up being just as important as figuring out which stocks to buy. As the stock market continues to trade near record levels, investors will be closely following trading action heading into the latter half of the year. With many stocks reaching new highs, investors may need to make sure that they aren’t getting too overconfident with trades. When a few winning trades are strung together, investors may feel like they have the Midas touch and they can do no wrong. Nobody knows for sure how long stocks will stay in favor with investors. Keeping track of the portfolio’s contents can help when quick decisions need to be made. There may come a time when the tide turns and making a winning trade may seem impossible. Investors might want to have a plan in place in case of a sudden major market downturn. Keeping the portfolio stable during periods of market uncertainty may help prepare for unforeseen events in the future. Although there are many market enthusiasts that think the bull run may be on its last legs, there are just as many who believe that the best is yet to come, and there is much mor  e room for stocks to climb. 

At the time of writing, BioMarin Pharmaceutical Inc. (NasdaqGS:BMRN) has a Piotroski F-Score of 4. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.

Some of the best financial predictions are formed by using a variety of financial tools. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks.  The Price Range of BioMarin Pharmaceutical Inc. (NasdaqGS:BMRN) over the past 52 weeks is 0.889000.  The 52-week range can be found in the stock’s quote summary. 

Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow.  The FCF Growth of BioMarin Pharmaceutical Inc. (NasdaqGS:BMRN) is 1.000000.  Free cash flow (FCF) is the cash produced by the company minus capital expenditure.  This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends.  The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow.  The FCF Score of BioMarin Pharmaceutical Inc. is 1.581585.  Experts say the higher the value, the better, as it means that the free cash flow is high, or the variability of free cash flow is low or both.

We can now take a quick look at some historical stock price index data. BioMarin Pharmaceutical Inc. (NasdaqGS:BMRN) presently has a 10 month price index of 1.18101. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 1.13208, the 24 month is 1.04604, and the 36 month is 1.40674. Narrowing in a bit closer, the 5 month price index is 0.96688, the 3 month is 1.01300, and the 1 month is currently 1.00362.

Investors may be interested in viewing the Gross Margin score on shares of BioMarin Pharmaceutical Inc. (NasdaqGS:BMRN). The name currently has a score of 20.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative. The Q.i. Value of BioMarin Pharmaceutical Inc. is 60.00000.  The Q.i. Value is a helpful tool in determining if a company is undervalued or not.  The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity.  The lower the Q.i. value, the more undervalued the company is thought to be.

The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price.  The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital.  The MF Rank of BioMarin Pharmaceutical Inc. (NasdaqGS:BMRN) is 12512.  A company with a low rank is considered a good company to invest in.  The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.  The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.  The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.  The ERP5 of BioMarin Pharmaceutical Inc. (NasdaqGS:BMRN) is 14768.  The lower the ERP5 rank, the more undervalued a company is thought to be.

There are various ways that the individual investor can approach stock picking. Starting from the top-down, investors may study overall market trends. This may include examining different sectors looking for the ones that are poised to prosper in the future. Once potential industries or sectors are identified, the investor can then start to sift through individual stocks within those groups. Investors starting from the bottom up may do just the opposite. They may choose to study individual companies that have been displaying strong performance, regardless of which sector they belong to. 

The 12 month volatility of W.W. Grainger, Inc. (NYSE:GWW) is 32.431900.  This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.  Stock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The lower the number, a company is thought to have low volatility.  The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months.  The Volatility 3m of W.W. Grainger, Inc. (NYSE:GWW) is 30.995100.  The Volatility 6m is the same, except measured over the course of six months.  The Volatility 6m is 31.959600.

Amateur investors can sometimes become overwhelmed by the speed and volatility of the stock market. Often times, avoiding big mistakes early on can be the difference between staying in the game or being prematurely forced to the sidelines. One of the biggest mistakes that a new investor can make is not creating a realistic plan. A well-crafted plan will generally include risk tolerance, time horizon, and amount and frequency of investments. Having a clear plan for attaining goals can help the investor stay focused when the terrain gets rocky. Another common mistake for investors is buying high and selling low. Of course, everybody preaches the buy low sell high mantra, but it is much easier said than done. Getting caught up in the day to day market swings can lead the investor to do just the opposite and become a hot stock chaser instead of a disciplined decision maker.

We can now take a quick look at some historical stock price index data. W.W. Grainger, Inc. (NYSE:GWW) presently has a 10 month price index of 1.04284. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 1.13495, the 24 month is 1.21873, and the 36 month is 1.54111. Narrowing in a bit closer, the 5 month price index is 0.85690, the 3 month is 1.03466, and the 1 month is currently 1.05603.

At the time of writing, W.W. Grainger, Inc. (NYSE:GWW) has a Piotroski F-Score of 8. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.

Investors may be interested in viewing the Gross Margin score on shares of W.W. Grainger, Inc. (NYSE:GWW). The name currently has a score of 3.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative. The Q.i. Value of W.W. Grainger, Inc. is 30.00000.  The Q.i. Value is a helpful tool in determining if a company is undervalued or not.  The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity.  The lower the Q.i. value, the more undervalued the company is thought to be.

The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price.  The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital.  The MF Rank of W.W. Grainger, Inc. (NYSE:GWW) is 2436.  A company with a low rank is considered a good company to invest in.  The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.  The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.  The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.  The ERP5 of W.W. Grainger, Inc. (NYSE:GWW) is 4691.  The lower the ERP5 rank, the more undervalued a company is thought to be.

Some of the best financial predictions are formed by using a variety of financial tools. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks.  The Price Range of W.W. Grainger, Inc. (NYSE:GWW) over the past 52 weeks is 0.814000.  The 52-week range can be found in the stock’s quote summary. 

Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow.  The FCF Growth of W.W. Grainger, Inc. (NYSE:GWW) is 0.169456.  Free cash flow (FCF) is the cash produced by the company minus capital expenditure.  This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends.  The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow.  The FCF Score of W.W. Grainger, Inc. is 0.792965.  Experts say the higher the value, the better, as it means that the free cash flow is high, or the variability of free cash flow is low or both.

Looking at stock market performance over the last few months, new investors may be worried that they might have missed out on some fantastic opportunities. With so much information and data available, they may not even know where to begin when getting into the stock investing arena. Everybody has to start somewhere, and becoming knowledgeable about the basics may help provide the perfect springboard from which to launch. Starting with the basics may help the investor understand the bigger picture which can then be filtered down into specifics. Because there is no magic formula to achieving success in the stock market, investors may have to explore many different strategies before choosing one to run with.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.